Temodar Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Study to Evaluate Safety and Efficacy of BEY1107 in Combination With Temozolomide in Patients With Recurrent or Progressive Glioblastoma Multiforme (GBM)
Condition:   Glioblastoma Multiforme Interventions:   Drug: BEY1107;   Combination Product: Temozolomide Sponsor:   BeyondBio Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2023 Category: Research Source Type: clinical trials

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Conditions:   Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype;   Astrocytoma, Grade III Interventions:   Drug: Debio 0123;   Drug: Temozolomide;   Radiation: Radiotherapy Sponsor:   Debiopharm International SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2023 Category: Research Source Type: clinical trials